Hong Kong Stock Movement | Valiant-B (09887.HK) rises over 6% again as Valiant's phase II study for first-line treatment of hepatocellular carcinoma enters the expansion stage.

Zhizhong Financial APP has learned that Weilizhibo-B (09887.HK) has risen over 6% again, with a cumulative increase of over 36% this month. As of the time of writing, it has risen by 6.07%, trading at HKD 73.35, with a transaction volume of HKD 131 million.